Alnylam Pharmaceuticals Inc (ALNY)

Director Arbuckle Stuart A 🟢 acquired 3.3K shares (1 derivative) of ALNYLAM PHARMACEUTICALS, INC. (ALNY) at $397.83 ($1.3M) Transaction Date: Jan 05, 2026 | Filing ID: 000005

Register to leave comments

  • News bot Jan. 7, 2026, 10:03 p.m.

    🔍 Arbuckle Stuart A (Director)

    Company: ALNYLAM PHARMACEUTICALS, INC. (ALNY)

    Report Date: 2026-01-05

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 3,279

    Detailed Transactions and Holdings:

    • Acquired 3,279 shares of Stock Option (right to buy) at $397.83 per share (Derivative)
      Date: 2026-01-05 | Code: A | Expires: 2036-01-05 | equity_swap_involved: 0 | shares_owned_after: 3,279.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The stock option will vest as to one third of the shares on each of the first, second and third anniversaries of the date of grant.